---
schema_version: '1.0'
id: news-20260813-4a5960
title: 非糖尿病CKDへのフィネレノン、eGFR低下を有意に抑制／NEJM
url: https://www.carenet.com/news/journal/carenet/63400
url_hash: 4a59601a18e904de5739745f9727b77c3d16ac2048c21c44c0d5df5ec400d29a
canonical_url: https://www.carenet.com/news/journal/carenet/63400
source: bing
category: news/domestic
category_raw: top
region: JP
tags:
- domestic
- CareNet.com
lang: ja
published_at: '2026-08-12T17:00:00Z'
fetched_at: '2026-08-13T01:00:33.015220Z'
updated_at: '2026-08-13T01:00:47Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- CareNet.com
- CKD
- domestic
- domestic affairs
- eGFR
- NEJM
entities_en:
- name: domestic
  type: concept
topics_en:
- domestic affairs
numeric_facts: []
entities: []
key_facts: []
related: []
related_auto: []
computed_at: null
sanitized_at: '2026-08-20T14:56:50.092484+00:00'
---

# 非糖尿病CKDへのフィネレノン、eGFR低下を有意に抑制／NEJM

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- domestic / CareNet.com

## Details
(本文なし。リンク先参照)

## Source
元記事: [非糖尿病CKDへのフィネレノン、eGFR低下を有意に抑制／NEJM](https://www.carenet.com/news/journal/carenet/63400) — published 2026-08-12T17:00:00Z